NCT06314555View on ClinicalTrials.gov

Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia

CompletedOBSERVATIONAL

Enrollment

314

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions

Preeclampsia Possible

Interventions

OTHER

Blood sample

Blood sample to analyse the values of sFlt-1 and PlGF

OTHER

Vascular-renal sample

Usual vascular-renal sample to analyse the values of sFlt-1 and PlGF

Trial Locations (1)

42100

Chu Saint Etienne, Saint-Etienne

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06314555 - Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia | Biotech Hunter | Biotech Hunter